Drug Discovery Chemistry

Speakers

Speakers
Anti-inflammatories
• Jean-Luc Galzi, Ph.D., Professor, Biotechnology and Cellular Signaling, University of Strasbourg
• Jean-Luc Girardet, Ph.D., Vice President, Chemistry & Development Support, Ardea Biosciences, Inc.
• Jan Hoflack, Ph.D., Head, Drug Discovery, ONCODESIGN Biotechnology
• Hayat Onyuksel, Ph.D., Professor, Biopharmaceutical Sciences, University of Illinois at Chicago
• Samarjit Patnaik, Ph.D., Research Scientist, National Center for Advancing Translational Sciences, NIH
• Peter H. Schafer, Ph.D., Senior Principal Investigator, Translational Development, Celgene Corporation
• C. Eric Schwartz, Ph.D., Senior Director, Chemistry, Celgene Avilomics Research
• Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate
• Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.
• Suvit Thaisrivongs, Ph.D., Executive Director, Chemistry, Pfizer
• Jennifer Venable, Ph.D., Senior Scientist, Immunology Chemistry, Johnson & Johnson Pharmaceutical R&D
• Longcheng Wang, Ph.D., Research Scientist III, Medicinal Chemistry, Pharmacyclics
• Daigen Xu, M.D., Ph.D., Research Leader, Inflammation Discovery, Hoffman La-Roche
• Mark Zak, Ph.D., Scientist, Discovery Chemistry, Genentech

Fragment-Based Drug Discovery
• Rommie E. Amaro, Ph.D., Assistant Professor, Department of Chemistry, University of California, San Diego
• Carol Austin, Ph.D., Biology Group Leader, Selcia Ltd
• Justin Bower, Ph.D., Head, Chemistry, Drug Discovery Programme, The Beatson Institute for Cancer Research
• Fabrizio Giordanetto, Ph.D., Project Leader – Principal Scientist, Medicinal Chemistry, CVGI iMed, AstraZeneca R&D
• Roderick E. Hubbard, Ph.D., Senior Scientist, Vernalis Ltd.
• Peter S. Kutchukian, Ph.D., Presidential Postdoctoral Fellow, Novartis Institutes for BioMedical Research, Cambridge, MA
• Alex MacKerell, Ph.D., Grollman-Glick Professor of Pharmaceutical Sciences; Director, Computer-Aided Drug Design Center School of Pharmacy University of Maryland
• Julen Oyarzabal, Ph.D., Director, Small Molecule Discovery Platform, Center for Applied Medical Research (CIMA), University of Navarra
• Joerg Scheuermann, Ph.D., Senior Scientist, MoB, Pharmaceutical Sciences, ETH Zurich
• David Soriano del Amo, Ph.D., Head, Med. Chemistry, Acelelra Ltd.
• Joe Sweeney, Ph.D., Professor of Catalysis and Chemical Biology, Department of Chemistry, University of Huddsfield
• Richard Taylor, Ph.D., Principal Scientist, CADD, UCB
• Heather Twin, Ph.D., Research Scientist, Vertex Pharmaceuticals
• Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group
• Edward T. Zartler, Ph.D., President and CSO, Quantum Tessera Consulting and ZoBio

Constrained Peptides and Macrocyclics Drug Discovery
• Steven Ballet, Ph.D., Research Group of Organic Chemistry, Departments of Bio-Engineering Sciences and Chemistry, Vrije Universiteit Brussel
• Christophe Bonny, Ph.D., CSO, Bicycle Therapeutics Limited
• Julio Camarero, Ph.D., Associate Professor, Pharmacology and Chemistry, University of Southern California
• Jennifer Cochran, Ph.D., Associate Professor, Bioengineering, Stanford University
• Sarah Dong, Ph.D., Senior Scientist II, Chemistry Department, Affymax, Inc.
• Ian Lewis, Ph.D., Research Chemist, Global Discovery Chemistry, Novartis
• Daniel Obrecht, Ph.D., CSO, Polyphor, Ltd.
• Dinesh Patel, Ph.D., CEO, Protagonist Therapeutics
• Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics
• Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate
• Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.
• Helmut Thomas, Ph.D., Senior Vice President, Research and Pre-Clinical Development, Tranzyme Pharma
• Douglas A. Treco, Ph.D., President and CEO, Ra Pharmaceuticals
• Christoph Zapf, Ph.D., Principal Scientist, Worldwide Medicinal Chemistry, Pfizer

Kinase Inhibitor Chemistry
• Toru Asano, Ph.D., Scientist, Drug Discovery Research, Astellas Pharma, Inc.
• Ann Aulabaugh, Ph.D., Senior Scientist, Structural Biology and Biophysics, Pfizer
• David Chantry, Ph.D., Senior Director, Translational and Cellular Biology, Array BioPharma
• Olivier Defert, Ph.D., Amakem NV
• Anthony Estrada, Ph.D., Scientist, Medicinal Chemistry, Genentech, Inc.
• Kristine E. Frank, Ph.D., Senior Scientist III, Hit to Lead Chemistry, Abbvie
• Leyi Gong, Ph.D., Scientist, SRI International
• Seungil Han, Ph.D., Senior Principal Scientist, Pfizer
• Jan Hoflack, Ph.D., Head, Drug Discovery, ONCODESIGN Biotechnology
• Sarah G. Hymowitz, Ph.D., Director, Department of Structural Biology, Genentech, Inc.
• Ramesh Jha, Ph.D., Scientist, Bioscience Division, B10, MS M888, Los Alamos National Laboratory
• Deborah J. Moshinsky, Ph.D., Founder and President, Cell Assay Innovations, LLC.
• Tom Smithgall, Ph.D., William S. McEllroy Professor of Biochemistry, Chair, Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine
• Hongtao Zhao, Ph.D., Scientist, Biochemistry, University of Zurich

Protein-Protein Interactions
• Cheryl Arrowsmith, Ph.D., Professor, Medical Biophysics; Canada Research Chair in Structural Proteomics, University of Toronto
• Carol Austin, Ph.D., Biology Group Leader, Selcia Ltd
• Asfar Azmi, Ph.D., Research Scientist, Pathology and Oncology, Karmanos Cancer Institute, Wayne State University
• James Bibb, M.D., Associate Professor, Psychiatry and Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center
• Peter Buchwald, Ph.D., Director, Drug Discovery, Diabetes Research Institute, University of Miami
• David Fry, Ph.D., Head, Biostructural Research, Hoffman-La Roche
• Chang-Deng Hu, M.D., Ph.D., Associate Professor, Medicinal Chemistry and Molecular Pharmacology, Purdue University
• Michael Hodsdon, M.D., Ph.D., Associate Professor, Laboratory Medicine, Yale University
• David Koes, Ph.D., Research Assistant Professor, Computational and Systems Biology, University of Pittsburgh
• Jarek Meller, Ph.D., Associate Professor, Environmental Health, University of Cincinnati
• Xavier Morelli, Ph.D., Group Leader & Principal Investigator, CRCM, CNRS
• Nir Qvit, Ph.D., Research Associate, Chemical and Systems Biology, Stanford University
• Tomi K. Sawyer, Ph.D., CSO, Aileron Therapeutics
• Adam G. Schrum, Ph.D., Assistant Professor of Immunology, Mayo Clinic College of Medicine
• Woody Sherman, Vice President, Applications Science, Schrödinger
• Olivier Sperandio, Ph.D., Drug Designer – CDithem Platform, Senior Research Associate, Inserm

GPCR-Based Drug Design: Computational and Structural Approaches
• Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
• Vadim Cherezov, Ph.D., Assistant Professor, Department of Molecular Biology, The Scripps Research Institute
• Robert Cooke, Ph.D., Head, Biomolecular Structure Department, Heptares
• Karen J. Gregory, Ph.D., Post-Doctoral Fellow, Jeffrey Conn Laboratory, Pharmacology, Vanderbilt University
• Reinhard Grisshammer, Ph.D., Investigator, National Institute of Neurological Disorders and Stroke (NINDS), NIH
• Andrew C. Kruse, Graduate Student, Brian Kobilka (2012 Nobel Laureate) Lab, Department of Molecular and Cellular Physiology, Stanford University
• Christopher A. Reynolds, Ph.D., MRC Fellow, Professor, School of Biological Sciences, University of Essex
• Hugh Rosen, M.D., Ph.D., Professor, Chemical Physiology, Scripps Research Institute
• Carleton Sage, Ph.D., Fellow, Computational Systems, Arena
• Thomas P. Sakmar, M.D., Professor, Laboratory of Chemical Biology & Signal Transduction, The Rockefeller University
• Jan Steyaert, Ph.D., Executive Director and Professor, Molecular and Cellular Interactions, Free University Brussels
• Nagarajan Vaidehi, Ph.D., Professor, Immunology, Beckman Research Institute of the City of Hope
• Graham West, Ph.D., Postdoctoral Associate, Molecular Therapeutics, The Scripps Research Institute, Scripps Florida